Filter
2511
Filtered Results: 2511
Text search:
African
Union
Featured
Recommendations
212
New Publications
587
Language
Document type
No document type
1376
Studies & Reports
556
Guidelines
216
Manuals
96
Strategic & Response Plan
90
Fact sheets
89
Infographics
25
Training Material
23
Situation Updates
15
Resource Platforms
12
Brochures
11
Dashboards/Maps
1
Online Courses
1
Countries / Regions
Africa
139
Global
99
West and Central Africa
89
Kenya
83
Sierra Leone
74
East and Southern Africa
67
Middle East and North Africa
67
Western and Central Europe
65
Liberia
63
Nigeria
62
Uganda
52
Zambia
47
Ethiopia
46
Syria
41
Malawi
41
South Sudan
40
South Africa
40
Senegal
38
Mozambique
38
Rwanda
37
Ghana
36
India
33
Congo, Democratic Republic of
31
Central African Republic
30
Zimbabwe
29
Guinea
28
Angola
27
Yemen
27
Lesotho
23
Myanmar / Burma
21
Benin
20
Namibia
20
Guinea-Bissau
19
Burkina Faso
18
Tanzania
18
Ukraine
18
Bangladesh
17
Latin America and the Carribbean
15
Germany
13
Eswatini/ Swaziland
13
Botswana
13
Eastern Europe
13
Nepal
11
Asia
11
Cameroon
10
Cambodia
9
Madagascar
9
Russia
9
Mali
8
Côte d’Ivoire / Ivory Coast
8
Indonesia
8
Sudan
8
Eastern Europe and Central Asia
8
Philippines
7
Somalia
7
Haiti
6
Pakistan
6
Jordan
5
Afghanistan
5
Chad
5
Libya
5
South–East Asia Region
5
Vietnam
5
Niger
4
Iraq
4
Egypt
4
Thailand
4
China
4
Brazil
4
Venezuela
4
Greece
3
Mexico
3
Sri Lanka
3
Western Pacific Region
3
Laos
3
Mauritius
3
Portugal
3
Saudi Arabia
2
Lebanon
2
Turkey
2
Colombia
2
Southern Africa
2
Tajikistan
2
Moldova
2
Iran
2
Kyrgyzstan
2
Turkmenistan
2
Jamaica
2
Japan
2
Tunisia
2
Spain
2
Morocco
1
Togo
1
Gambia
1
Papua New Guinea
1
Argentina
1
Dominican Republic
1
Peru
1
Serbia
1
Croatia
1
Honduras
1
Poland
1
Palestine
1
Italy
1
Djibouti
1
Armenia
1
Bulgaria
1
Romania
1
Kazakhstan
1
North America
1
Gabon
1
United Kingdom
1
Azerbaijan
1
Israel
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
976
Public Health
133
Clinical Guidelines
118
Key Resources
101
Women & Child Health
78
Pharmacy & Technologies
40
Capacity Building
17
Toolboxes
COVID-19
320
TB
241
HIV
165
Mental Health
124
Disability
123
Planetary Health
120
Ebola
96
Refugee
77
AMR
73
Conflict
68
Rapid Response
65
Health Financing Toolbox
58
Global Health Education
51
Pharmacy
41
Caregiver
39
NTDs
35
NCDs
30
Polio
18
Natural Hazards
18
Specific Hazards
13
Social Ethics
10
Zika
9
Cholera
2
Typhoon
1
The present information document supplements the WHO audited financial statements for 2018. It contains information on WHO's voluntary contributions by fund and by contributor in the year 2018.
Development finance institutions owned by European governments and the World Bank Group are spending hundreds of millions of dollars on expensive for-profit hospitals in the Global South that block patients from getting care, or bankrupt them, with some even imprisoning patients who cannot afford th...
Background: In 2015, 5.3 million babies died in the third trimester of pregnancy and first month following birth. Progress in reducing neonatal mortality and stillbirth rates has lagged behind the substantial progress in reducing postneonatal and maternal mortality rates. The benefits to prenatal an...
The environment in which young people live, learn and play significantly affects their decisions about whether to consume alcohol. Environmental factors are the main risk factors driving alcohol consumption and related harm among young people. Environments that normalize alcohol consumption – term...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
Four initiatives have estimated the value of aid for reproductive, maternal, newborn, and child health
(RMNCH): Countdown to 2015, the Institute for Health Metrics and Evaluation (IHME), the Muskoka Initiative, and
the Organisation for Economic Co-operation and Development (OECD) policy marker. We...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...
A year ago, the second Special Session of the World Health Assembly (WHASS) unanimously agreed to start a diplomatic process for a new binding instrument aimed at ensuring the international community is better prepared for the next health emergencies. The establishment of an Intergovernmental Negoti...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
Developed as part of the UN Women–WHO Global Joint Programme on Violence Against Women Data, this briefing note focuses on the measurement of violence against women with disability and is one in a series of methodological briefing notes for strengthening the measurement and data collection of viol...
There is increasing interest in understanding the role of air pollution as one of the greatest threats to human health worldwide. Nine of 10 individuals breathe air with polluted compounds that have a great impact on lung tissue. The nature of the relationship is complex, and new or updated data are...
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on considerations for medical device solicitation and provisi...
Asthma is the most common chronic disease in children, imposing a consistent burden on health system. In recent years, prevalence of asthma symptoms became globally increased in children and adolescents, particularly in Low-Middle Income Countries (LMICs). Host (genetics, atopy) and environmental fa...
Chronic respiratory diseases, such as asthma and
chronic obstructive pulmonary disease, kill more than
four million people every year and affect hundreds
of millions more. These diseases erode the health
and well-being of the patients and have a negative
impact on families and societies. Women ...
The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
The United Nations Framework Convention on Climate Change (UNFCCC) established its Financial Mechanism to facilitate the provision and transfer of resources from developed to developing countries. The Global Environment Facility became the first operating entity of the Financial Mechanism after the ...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma...
